Navigation Links
Study Downgrades Gene as Heart Risk Factor
Date:9/18/2007

Screening for variations in APO gene not warranted, researchers say

TUESDAY, Sept. 18 (HealthDay News) -- Variations in the apolipoprotein (APO) gene are not as important an indicator of coronary risk as has been thought, according to a new British analysis of previously published studies.

The APO gene comes in three varieties -- E2, E3 and E4. All forms of the gene produce a protein that is an important component of the fat and protein complexes found in blood plasma, and that plays an important role in the metabolism of cholesterol and the fats called triglycerides.

Some previous studies have found an association between specific APOE versions -- generally E2 -- and lipid levels, according to the report, published in the Sept. 19 issue of the Journal of the American Medical Association by a group led by John Danesh of the University of Cambridge.

But many of those studies were too small to be reliable, said study co-author Dr. Emanuele Di Angelantonio. A meta-analysis that assessed 82 studies of blood fat levels and 121 studies of coronary outcome showed that the association with APO E variants showed that the links were not as strong as once suspected, he said.

"People with APO E2 have a 20 percent lower risk of coronary disease," Di Angelantonio said. That was about twice as weak as had been previously reported, the journal report said. Coronary risk was increased slightly for carriers of the APO E4 variant.

There has been talk about screening for APO E variants to help determine coronary risk, but "it is almost impossible to use APO E for screening," Di Angelantonio said. "APO E2 is a relatively rare mutation."

Which is just as well, said Dr. Daniel J. Rader, director of preventive cardiology at the University of Pennsylvania, since APO E variants can affect the risk of other conditions. Specifically, APO E4 has been linked to an increased risk of Alzheimer's disease, Rader noted.

"I actually did APO screening for a while," he said. "I found myself in the awkward position of having to explain what APO E4 means in terms of Alzheimer's disease."

The new meta-analysis does confirm "what we've known for some time, that APO E is one of the more important genes that determine the risk of heart disease," Rader said. "But it is a great example of why we need federal legislation in terms of protecting people in genetic screening programs."

Positive steps can be taken to reduce the risk of coronary disease for those carrying a gene that increases the risk, Rader said. "But for Alzheimer's, we can do nothing. If you carry E4, you might be subject to discrimination."

Such a screening program involving APO E is highly unlikely now, Di Angelantonio said. "It is too early to speak about assessing coronary risk with genotypes, and this study demonstrates that," he said.

More information

More on heredity as a risk factor for heart disease is provided by the American Heart Association.



SOURCES: Emanuele Di Angelantonio, M.D., research associate, University of Cambridge, England; Daniel J. Rader, director, preventive cardiology, University of Pittsburgh; Sept. 19, 2007, Journal of the American Medical Association


'/>"/>
Copyright©2007 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Rural Canadians travel far for specialists: study
2. A new study surpasses Gene Therapy Hurdle
3. Tomato Sauce reduces Cancer Risk- Study
4. A question on study of Adult Stem Cell
5. Study on obesity and heart failure
6. National Lung Study in the process
7. Marijuana gateway theory strengthened by study of twins
8. Old theory of adaptation confirmed by new study
9. Study casts doubt on keyboard ills
10. Gene study links endometriosis, infertility
11. Study reveals how stress can make you sick
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic events may suffer ... unhealthy avenues, such as drug or alcohol abuse, as a coping mechanism. To avoid ... healthy coping following a traumatic event. , Trauma sufferers tend to feel a range ...
(Date:6/24/2016)... ... ... Marcy was in a crisis. Her son James, eight, was out of control. Prone to ... , “When something upset him, he couldn’t control his emotions,” remembers Marcy. “If there ... my other children and say he was going to kill them. If we were ...
(Date:6/24/2016)... ... 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced that 20 ... by their peers for this recognition are considered among the top 2 percent of ... honors as members of this year’s Legal Elite Hall of Fame: Miami Shareholders ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, CA is excited ... To Recovery® program to drive cancer patients to and from their cancer treatments. ... highest quality of life and ongoing independence. Getting to and from medical treatments ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. ... magazine’s Code Talker Award, an essay contest in which patients and their families pay ... be presented at the 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 Research ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, ... (Oral, Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is ... a CAGR of 6.1% in the forecast period 2016 ...
(Date:6/23/2016)... June 23, 2016 Research and Markets ... Issue 52" report to their offering. ... treatment creates a favourable commercial environment for MedImmune to enter. ... base that will serve to drive considerable growth for effective ... serve to cap sales considerably, but development is still in ...
(Date:6/23/2016)... LONDON , June 23, 2016 ... environments  Oticon , industry leaders in ... the launch of Oticon Opn ™, the world,s ... world of possibilities for IoT devices.      ... Opn, Oticon introduces a number of ,world firsts,: ...
Breaking Medicine Technology: